FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Franz Messerli

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Hemodynamics

Anatomy

Renin-Angiotensin System

Co-author Network

Publications

TOP 3
Alexandros Briasoulis; Vikram Agarwal; Antonis Valachis; Franz H Messerli
Antihypertensive effects of statins: a meta-analysis of prospective controlled studies.
Sripal Bangalore; Franz H Messerli
Toward a more responsible news media.
Sripal Bangalore; Sunil Kumar; Alexander Volodarskiy; Franz H Messerli
Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Franz Messerli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alexandros Briasoulis; Vikram Agarwal; Antonis Valachis; Franz H Messerli
Antihypertensive effects of statins: a meta-analysis of prospective controlled studies.
Journal of clinical hypertension (Greenwich, Conn.) 2013;15(5):310-20.
2013: Sripal Bangalore; Franz H Messerli
Toward a more responsible news media.
The American journal of medicine 2013;126(5):370-2.
2013: Sripal Bangalore; Sunil Kumar; Alexander Volodarskiy; Franz H Messerli
Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials.
Heart (British Cardiac Society) 2013;99(9):601-13.
2013: Neel P Chokshi; Ehud Grossman; Franz H Messerli
Blood pressure and diabetes: vicious twins.
Heart (British Cardiac Society) 2013;99(8):577-85.
2013: Franz H Messerli; Sripal Bangalore
Treatment-resistant hypertension: another Cinderella story.
European heart journal 2013;34(16):1175-7.
2013: Edgar Argulian; Emad F Aziz; Firas Kaddaha; Bette Kim; Franz H Messerli; Vikram Agarwal; Glenda Winson; Mark V Sherrid
Antihypertensive therapy in hypertrophic cardiomyopathy.
The American journal of cardiology 2013;111(7):1040-5.
2013: Franz H Messerli; Jan A Staessen; Christian Torp-Pedersen; Sripal Bangalore; John B Kostis
Cardiovascular drugs and cancer: of competing risk, smallpox, Bernoulli, and d'Alembert.
European heart journal 2013;34(15):1095-8.
2013: Franz H Messerli; Sripal Bangalore
ALTITUDE trial and dual RAS blockade: the alluring but soft science of the surrogate end point.
The American journal of medicine 2013;126(3):e1-3.
2013: Franz H Messerli; Sripal Bangalore
Diuretic-based regimens for obese patients?
Lancet 2013;381(9866):512-3.
2013: Carlos L Alviar; Sripal Bangalore; Alexandre Benjo; Santhosh Devarapally; Bryan Doherty; Fahad Javed; Hyuensok Kang; Girish N Nadkarni; Jorge Romero; Franz H Messerli
Efficacy and safety of dual calcium channel blockade for the treatment of hypertension: a meta-analysis.
American journal of hypertension 2013;26(2):287-97.
2013: Dan G Halpern; Franz H Messerli; Vikram Agarwal; Edgar Argulian; Wallacy Garcia; Jacqueline Tamis-Holland
Beta-blockers for blood pressure augmentation.
Journal of hypertension 2013;31(2):422-3.
2013: Franz H Messerli; Harikrishna Makani; Sripal Bangalore
Authors' reply to Laragh and Sealey.
BMJ (Clinical research ed.) 2013;346():f1689.
2013: Harikrishna Makani; Sripal Bangalore; Kavit A Desouza; Arpit Shah; Franz H Messerli
Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials.
BMJ (Clinical research ed.) 2013;346():f360.
2012: Sripal Bangalore; Franz H Messerli
Statin therapy for secondary prevention: is there a gender difference? Test for interaction in meta-analysis revisited.
The American journal of cardiology 2012;110(10):1553-4.
2012: Neel P Chokshi; Franz H Messerli; Azhar A Supariwala; David Sutin; Nirav R Shah
Appropriateness of statins in patients aged ≥80 years and comparison to other age groups.
The American journal of cardiology 2012;110(10):1477-81.
2012: Alexandros Briasoulis; Vikram Agarwal; Franz H Messerli
Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis.
Journal of clinical hypertension (Greenwich, Conn.) 2012;14(11):792-8.
2012: Sripal Bangalore; Deepak L Bhatt; Christopher P Cannon; Kevin Crowley; Prakash Deedwania; Kim A Eagle; Shinya Goto; Elaine B Hoffman; Franz H Messerli; E Magnus Ohman; Sidney C Smith; Gabriel Steg; Uwe Zeymer
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
JAMA : the journal of the American Medical Association 2012;308(13):1340-9.
2012: Kashif N Chaudhry; Patricia Chavez; Jerzy Gasowski; Tomasz Grodzicki; Franz H Messerli
Hypertension in the elderly: some practical considerations.
Cleveland Clinic journal of medicine 2012;79(10):694-704.
2012: Sverre E Kjeldsen; Peter A Meredith; Franz H Messerli; Chern-En Chiang; Lisheng Liu
Are fixed-dose combination antihypertensives suitable as first-line therapy?
Current medical research and opinion 2012;28(10):1685-97.
2012: Edgar Argulian; Dan G Halpern; Eyal Herzog; Franz H Messerli
Paradoxical hypertension with cardiac tamponade.
The American journal of cardiology 2012;110(7):1066-9.
2012: Haifeng Zhang; Franz H Messerli; Jan A Staessen
Secondary prevention after ischemic stroke.
The New England journal of medicine 2012;367(7):675; author reply 676-7.
2012: Ehud Grossman; Yehonatan Sharabi; Franz H Messerli
Thiazide-induced hyponatremia is predictable.
The American journal of medicine 2012;125(8):e9; author reply e11-2.
2012: Harikrishna Makani; Franz H Messerli; Jorge Romero; Omar Wever-Pinzon; Ronaldo Sevilla Berrios; Aleksander Korniyenko; Sripal Bangalore
Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors.
The American journal of cardiology 2012;110(3):383-91.
2012: Franz H Messerli; Sripal Bangalore
Cardiovascular death and cancer death--competing risk?
The American journal of cardiology 2012;109(11):1687.
2012: Tiberio M Frisoli; Tomasz Grodzicki; Roland E Schmieder; Franz H Messerli
Salt and hypertension: is salt dietary reduction worth the effort?
The American journal of medicine 2012;125(5):433-9.
2012: Gurusher S Panjrath; Sameer Chaudhari; Franz H Messerli
The j-point phenomenon in aggressive therapy of hypertension: new insights.
Current atherosclerosis reports 2012;14(2):124-9.
2012: Cesar Cerezo; Juan J de la Cruz; Jose A Garcia-Donaire; Ton J Rabelink; Luis M Ruilope; Julian Segura; Bernard Waeber; Jose R Banegas; Franz H Messerli
Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression.
Journal of hypertension 2012;30(1):204-9.
2011: Vikram Agarwal; Nidhi Hans; Gunjan Kant; Franz H Messerli
Takotsubo-like cardiomyopathy in pheochromocytoma.
International journal of cardiology 2011;153(3):241-8.
2011: Franz H Messerli; Sripal Bangalore
Half a century of hydrochlorothiazide: facts, fads, fiction, and follies.
The American journal of medicine 2011;124(10):896-9.
2011: Peter S Sever; Franz H Messerli
Hypertension management 2011: optimal combination therapy.
European heart journal 2011;32(20):2499-506.
2011: Franz H Messerli; Stefano F Rimoldi; Yves Allemann; Sripal Bangalore; Harikrishna Makani; Stephen Textor; Christopher J White; Peter Sleight
Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome.
European heart journal 2011;32(18):2231-5.
2011: Ehud Grossman; Franz H Messerli
Management of blood pressure in patients with diabetes.
American journal of hypertension 2011;24(8):863-75.
2011: Harikrishna Makani; Hetal Makwana; Sripal Bangalore; Ronaldo S Berrios; Nay Htyte; Jorge Romero; Franz H Messerli
Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate--a meta-analysis of randomized trials.
Journal of hypertension 2011;29(7):1270-80.
2011: Marrick Kukin; Franz H Messerli
Wireless pulmonary artery haemodynamic monitoring.
Lancet 2011;377(9784):2176-7; author reply 2177.
2011: Sripal Bangalore; Sunil Kumar; Iryna Lobach; Franz H Messerli
Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.
Circulation 2011;123(24):2799-810, 9 p following 810.
2011: Fahad Javed; Emad F Aziz; Manpreet S Sabharwal; Girish N Nadkarni; Shahzeb A Khan; Juan P Cordova; Alexandre Benjo; Dympna Gallagher; Eyal Herzog; Franz H Messerli; F Xavier Pi-Sunyer
Association of BMI and cardiovascular risk stratification in the elderly African-American females.
Obesity (Silver Spring, Md.) 2011;19(6):1182-6.
2011: Franz H Messerli; Harikrishna Makani; Dan Halpern
Gout.
The New England journal of medicine 2011;364(19):1876-7; author reply 1877.
2011: Aleksandr Korniyenko; Carlos L Alviar; Juan P Cordova; Franz H Messerli
Role of angiotensin-converting enzyme inhibitors in visceral angioedema.
International journal of cardiology 2011;148(3):377-9.
2011: Aleksandr Korniyenko; Carlos L Alviar; Juan P Cordova; Franz H Messerli
Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy.
Cleveland Clinic journal of medicine 2011;78(5):297-304.
2011: Sameer Ather; Sripal Bangalore; Srinath Vemuri; Long B Cao; Biykem Bozkurt; Franz H Messerli
Trials on the effect of cardiac resynchronization on arterial blood pressure in patients with heart failure.
The American journal of cardiology 2011;107(4):561-8.
2011: Harikrishna Makani; Sripal Bangalore; Jorge Romero; Omar Wever-Pinzon; Franz H Messerli
Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema.
The American journal of medicine 2011;124(2):128-35.
2011: Franz H Messerli; Harikrishna Makani; Alexandre Benjo; Jorge Romero; Carlos Alviar; Sripal Bangalore
Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials.
Journal of the American College of Cardiology 2011;57(5):590-600.
2011: Franz H Messerli; Sripal Bangalore
The Pickering Syndrome--a pebble in the mosaic of the cardiorenal syndrome.
Blood pressure 2011;20(1):1-2.
2011: Franz H Messerli; Sripal Bangalore
Blood pressure and stroke: findings from recent trials.
Journal of the American College of Cardiology 2011;57(1):114-5.
2011: Sripal Bangalore; Sunil Kumar; Jørn Wetterslev; Franz H Messerli
Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials.
BMJ (Clinical research ed.) 2011;342():d2234.
2011: Sripal Bangalore; Sunil Kumar; Sverre E Kjeldsen; Harikrishna Makani; Ehud Grossman; Jørn Wetterslev; Ajay K Gupta; Peter S Sever; Christian Gluud; Franz H Messerli
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
The lancet oncology 2011;12(1):65-82.
2010: Giacomo Rossitto; Ganesh Kamath; Franz H Messerli
Q: Should alpha-blockers ever be used as antihypertensive drugs?
Cleveland Clinic journal of medicine 2010;77(12):884-8.
2010: Sripal Bangalore; Franz H Messerli; Chuan-Chuan Wun; Andrea L Zuckerman; David DeMicco; John B Kostis; John C LaRosa
J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial.
European heart journal 2010;31(23):2897-908.
2010: Sripal Bangalore; Sunil Kumar; Franz H Messerli
Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference.
The American journal of medicine 2010;123(11):1016-30.
2010: Franz H Messerli; Jan A Staessen; Faiez Zannad
Of fads, fashion, surrogate endpoints and dual RAS blockade.
European heart journal 2010;31(18):2205-8.
2010: Sripal Bangalore; Franz H Messerli
Valsartan inefficacy or ill-effects of concomitant medications!
The American journal of cardiology 2010;106(4):602-3.
2010: Scott J Denardo; Franz H Messerli; Efrain Gaxiola; Juan M Aranda; Rhonda M Cooper-DeHoff; Eileen M Handberg; Yan Gong; Annette Champion; Qian Zhou; Carl J Pepine
Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]).
The American journal of cardiology 2010;106(4):498-503.
2010: Scott J Denardo; Yan Gong; Wilmer W Nichols; Franz H Messerli; Anthony A Bavry; Rhonda M Cooper-DeHoff; Eileen M Handberg; Annette Champion; Carl J Pepine
Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.
The American journal of medicine 2010;123(8):719-26.
2010: Franz H Messerli; Daniel Levy
Inappropriate priority claim.
Journal of hypertension 2010;28(8):1778; author reply 1778-9.
2010: Franz H Messerli; Harikrishna Makani
Does glutamic acid lower blood pressure?
The American journal of cardiology 2010;105(11):1647.
2010: Fahad Javed; Emad F Aziz; Girish N Nadkarni; Shahzeb A Khan; Manpreet Singh Sabharwal; Rishi Malhan; Alexandre Benjo; Eyal Herzog; Franz H Messerli
The association of the Friesinger score and pulse pressure in an urban South Asian patient population: pulse pressure, an independent predictor of coronary artery disease.
Journal of the American Society of Hypertension : JASH 2010;4(3):142-7.
2010: Sripal Bangalore; Franz H Messerli; Fang-Shu Ou; Jacqueline Tamis-Holland; Angela Palazzo; Matthew T Roe; Mun K Hong; Eric D Peterson
The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative.
European heart journal 2010;31(5):552-60.
2010: Franz H Messerli; Sripal Bangalore
FDA drug information that never reaches clinicians.
The New England journal of medicine 2010;362(6):562; author reply 563.
2009: Sripal Bangalore; Franz H Messerli
Commentary: counterpoint. Simple-minded antihypertensive treatment: of assumptions, potpourri, and sausages.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(12):702-6.
2009: José R Banegas; Franz H Messerli; Bernard Waeber; Fernando Rodríguez Artalejo; Alejandro de la Sierra; Julián Segura; Alex Roca-Cusachs; Pedro Aranda; Luis M Ruilope
Discrepancies between office and ambulatory blood pressure: clinical implications.
The American journal of medicine 2009;122(12):1136-41.
2009: Franz H Messerli; Melana Yuzefpolskaya
Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic journal of medicine 2009;76(12):693-6.
2009: Franz H Messerli; Gurusher S Panjrath
The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?
Journal of the American College of Cardiology 2009;54(20):1827-34.
2009: Franz H Messerli; Sripal Bangalore; Frank Ruschitzka
Angiotensin receptor blockers: baseline therapy in hypertension?
European heart journal 2009;30(20):2427-30.
2009: Carl J Lavie; Franz H Messerli; Richard V Milani
Beta-blockers as first-line antihypertensive therapy the crumbling continues.
Journal of the American College of Cardiology 2009;54(13):1162-4.
2009: Franz H Messerli; Harikrishna Makani
Relentless progression toward sustained hypertension.
Hypertension 2009;54(2):217-8.
2009: Sripal Bangalore; Franz H Messerli; Stanley S Franklin; Giuseppe Mancia; Annette Champion; Carl J Pepine
Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
European heart journal 2009;30(11):1395-401.
2009: Alberto Zanchetti; Giuseppe Mancia; Henry R Black; Suzanne Oparil; Bernard Waeber; Roland E Schmieder; George L Bakris; Franz H Messerli; Sverre E Kjeldsen; Luis M Ruilope
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.
Journal of hypertension 2009;27(4):673-9.
2009: Sripal Bangalore; Sanobar Parkar; Franz H Messerli
Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis.
The American journal of medicine 2009;122(4):356-65.
2009: Scott J Denardo; Franz H Messerli; Efrain Gaxiola; Juan M Aranda; Rhonda M Cooper-DeHoff; Eileen Handberg; Yan Gong; Annette Champion; Qian Zhou; Carl J Pepine
Characteristics and outcomes of revascularized patients with hypertension: an international verapamil SR-trandolapril substudy.
Hypertension 2009;53(4):624-30.
2009: Sripal Bangalore; Franz H Messerli; Fang-Shu Ou; Jacqueline Tamis-Holland; Angela Palazzo; Matthew T Roe; Mun K Hong; eric peterson
Blood pressure paradox in patients with non-ST-segment elevation acute coronary syndromes: results from 139,194 patients in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) quality improvement initiative.
American heart journal 2009;157(3):525-31.
2009: Franz H Messerli
The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point.
Journal of the American College of Cardiology 2009;53(6):468-70.
2009: Franz H Messerli; Sripal Bangalore
Antihypertensive efficacy of aliskiren: is hydrochlorothiazide an appropriate benchmark?
Circulation 2009;119(3):371-3.
2009: Sripal Bangalore; Franz H Messerli
Drug prevention of hypertension. Assumptions and extrapolation.
BMJ (Clinical research ed.) 2009;338():b2600.
2008: Sripal Bangalore; Jørn Wetterslev; Shruthi Pranesh; Sabrina Sawhney; Christian Gluud; Franz H Messerli
Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis.
Lancet 2008;372(9654):1962-76.
2008: Sripal Bangalore; Franz H Messerli
Beta-blockers as fourth-line therapy for hypertension: stay the course.
International journal of clinical practice 2008;62(11):1643-6.
2008: Sripal Bangalore; Sabrina Sawhney; Franz H Messerli
Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension.
Journal of the American College of Cardiology 2008;52(18):1482-9.
2008: Sripal Bangalore; Christian Gluud; Jørn Wetterslev; Franz H Messerli
Perioperative beta blockade.
Lancet 2008;372(9644):1147-8; author reply 1148.
2008: Sripal Bangalore; David Wild; Sanobar Parkar; Marrick L Kukin; Franz H Messerli
Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis.
Journal of the American College of Cardiology 2008;52(13):1062-72.
2008: Franz H Messerli; Juerg Nussberger; Susan Phung
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker.
Kidney international 2008;74(6):825; author reply 825.
2008: Franz H Messerli; Sripal Bangalore
When guidelines need guidance...
The American journal of medicine 2008;121(9):742-3.
2008: Franz H Messerli; D J Eslava
Treatment of hypertensive emergencies: blood pressure cosmetics or outcome evidence?
Journal of human hypertension 2008;22(9):585-6.
2008: Franz H Messerli; Joanna Sulicka; Barbara Gryglewska
Treatment of hypertension in the elderly.
The New England journal of medicine 2008;359(9):972-3; author reply 973-4.
2008: Sripal Bangalore; Franz H Messerli; Jerome D Cohen; Peter H Bacher; Peter Sleight; Giuseppe Mancia; Peter Kowey; Qian Zhou; Annette Champion; Carl J Pepine
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
American heart journal 2008;156(2):241-7.
2008: Franz H Messerli; Sripal Bangalore; Venkata S Ram
Telmisartan, ramipril, or both in patients at high risk of vascular events.
The New England journal of medicine 2008;359(4):426-7; author reply 427.
2008: Ehud Grossman; Franz H Messerli
Secondary hypertension: interfering substances.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(7):556-66.
2008: Franz H Messerli
Immunization Against Angiotensin II.
Current hypertension reports 2008;10(3):171-2.
2008: Michael A Weber; Franz H Messerli
Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk.
Hypertension 2008;51(6):1465-7.
2008: Franz H Messerli; Sripal Bangalore; Stevo Julius
Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension.
Circulation 2008;117(20):2706-15; discussion 2715.
2008: Sripal Bangalore; Sheila Khianey; Franz H Messerli
Celecoxib and hypertension-insights from the effect of celecoxib on restenosis after coronary angioplasty with a taxus stent trial.
The American journal of cardiology 2008;101(7):1068.
2008: Michael A Weber; George L Bakris; Thomas D Giles; Franz H Messerli
Beta-blockers in the treatment of hypertension: new data, new directions.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(3):234-8.
2008: Franz H Messerli; Lionel Pinto; Simon S K Tang; Kamlesh M Thakker; Joseph C Cappelleri; Tina Sichrovsky; Robert W Dubois
Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysis.
The American journal of cardiology 2008;101(3):319-25.
2008: Nikolas Wanahita; Franz H Messerli; Sripal Bangalore; Apoor S Gami; Virend K Somers; Jonathan S Steinberg
Atrial fibrillation and obesity--results of a meta-analysis.
American heart journal 2008;155(2):310-5.
2008: Antonio Coca; Franz H Messerli; ATHANASE BENETOS; Qian Zhou; Annette Champion; Rhonda M Cooper-DeHoff; Carl J Pepine
Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.
Stroke; a journal of cerebral circulation 2008;39(2):343-8.
2008: Franz H Messerli; Sripal Bangalore
Resting heart rate and cardiovascular disease: the beta-blocker-hypertension paradox.
Journal of the American College of Cardiology 2008;51(3):330-1; author reply 331-2.
2008: Robert A Phillips; Vivian Fonseca; Richard E Katholi; Janet B McGill; Franz H Messerli; David S H Bell; Philip Raskin; Jackson T Wright; Malini Iyengar; Karen M Anderson; Mary Ann Lukas; George L Bakris
Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
Journal of the cardiometabolic syndrome 2008;3(4):211-7.
2008: Ehud Grossman; Franz H Messerli
Hypertension and diabetes.
Advances in cardiology 2008;45():82-106.
2007: Franz H Messerli; Henry Greenberg
Shattuck Lecture: improving American health.
The New England journal of medicine 2007;357(23):2406; author reply 2406-7.
2007: Eyal Herzog; Olivier Frankenberger; Emad Aziz; Sripal Bangalore; Sandhya K Balaram; E John Nasrallah; Stanley Cortell; Franz H Messerli
A novel pathway for the management of hypertension for hospitalized patients.
Critical pathways in cardiology 2007;6(4):150-60.
2007: Sripal Bangalore; Gayathri Kamalakkannan; Franz H Messerli
Beta-blockers: no longer an option for uncomplicated hypertension.
Current cardiology reports 2007;9(6):441-6.
2007: Jackson T Wright; George L Bakris; David S H Bell; Vivian Fonseca; Richard E Katholi; Janet B McGill; Franz H Messerli; Robert A Phillips; Philip Raskin; Fred K Holdbrook; Mary Ann Lukas; Malini Iyengar
Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(11):842-9.
2007: Sripal Bangalore; Franz H Messerli
Is there an ischemic threshold beyond which percutaneous coronary intervention is beneficial in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial?
The American journal of cardiology 2007;100(9):1495.
2007: Carl J Lavie; Richard V Milani; Hector O Ventura; Gustavo A Cardenas; Mandeep Mehra; Franz H Messerli
Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction.
The American journal of cardiology 2007;100(9):1460-4.
2007: Sripal Bangalore; Sabrina Sawhney; Franz H Messerli
Siesta, all-cause mortality, and cardiovascular mortality: is there a "siesta" at adjudicating cardiovascular mortality?
Archives of internal medicine 2007;167(19):2143.
2007: Sripal Bangalore; Sanobar Parkar; Ehud Grossman; Franz H Messerli
A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.
The American journal of cardiology 2007;100(8):1254-62.
2007: Seth Uretsky; Franz H Messerli; Sripal Bangalore; Annette Champion; Rhonda M Cooper-DeHoff; Qian Zhou; Carl J Pepine
Obesity paradox in patients with hypertension and coronary artery disease.
The American journal of medicine 2007;120(10):863-70.
2007: Richard N Re; Franz H Messerli
Renin excess after renin inhibition: malefactor or innocent bystander?
International journal of clinical practice 2007;61(9):1427-9.
2007: Franz H Messerli; Bryan Williams; Eberhard Ritz
Essential hypertension.
Lancet 2007;370(9587):591-603.
2007: Sripal Bangalore; Franz H Messerli; John B Kostis; Carl J Pepine
Cardiovascular protection using beta-blockers: a critical review of the evidence.
Journal of the American College of Cardiology 2007;50(7):563-72.
2007: Sripal Bangalore; Gayathri Kamalakkannan; Sanobar Parkar; Franz H Messerli
Fixed-dose combinations improve medication compliance: a meta-analysis.
The American journal of medicine 2007;120(8):713-9.
2007: Siu-Sun Yao; Franz H Messerli
Blood pressure control and sildenafil--carrot stick or sword of Damocles?
The American journal of cardiology 2007;100(3):552-3.
2007: Florent Boutitie; Roxana Oprisiu; Jean Michel Achard; Hakim Mazouz; Jiguang Wang; Franz H Messerli; François Gueyffier; Albert Fournier
Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II.
Journal of hypertension 2007;25(8):1543-53.
2007: Franz H Messerli; David S H Bell; Vivian Fonseca; Richard E Katholi; Janet B McGill; Robert A Phillips; Philip Raskin; Jackson T Wright; Sripal Bangalore; Fred K Holdbrook; Mary Ann Lukas; Karen M Anderson; George L Bakris
Body weight changes with beta-blocker use: results from GEMINI.
The American journal of medicine 2007;120(7):610-5.
2007: Vivian Fonseca; George L Bakris; David S H Bell; Janet B McGill; Philip Raskin; Franz H Messerli; Robert A Phillips; Richard E Katholi; Jackson T Wright; B Waterhouse; Mary Ann Lukas; Karen M Anderson
Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.
Diabetic medicine : a journal of the British Diabetic Association 2007;24(7):759-63.
2007: Franz H Messerli
Cerebroprotection by hypertension in ischemic stroke: the crumbling of a hypothesis.
Circulation 2007;115(23):2907-8.
2007: Sripal Bangalore; Anupama Shahane; Sanobar Parkar; Franz H Messerli
Compliance and fixed-dose combination therapy.
Current hypertension reports 2007;9(3):184-9.
2007: Franz H Messerli; Kevin R Loughlin; Adrian W Messerli; William R Welch
The president and the pheochromocytoma.
The American journal of cardiology 2007;99(9):1325-9.
2007: Franz H Messerli; Olga Kuteyeva
Bashing diuretics or failure of surrogate endpoint?
Journal of hypertension 2007;25(5):949-50.
2007: Janet B McGill; George L Bakris; Vivian Fonseca; Philip Raskin; Franz H Messerli; Robert A Phillips; Richard E Katholi; Jackson T Wright; Malini Iyengar; Karen M Anderson; Mary Ann Lukas; M R Dalal; David S H Bell
beta-blocker use and diabetes symptom score: results from the GEMINI study.
Diabetes, obesity & metabolism 2007;9(3):408-17.
2007: Sripal Bangalore; Franz H Messerli
Hypertension in the elderly: a compelling contraindication for beta-blockers?
Journal of human hypertension 2007;21(4):259-60.
2007: Franz H Messerli; Giuseppe Mancia; C Richard Conti; Carl J Pepine
Blood pressure levels on progression of coronary atherosclerosis.
Journal of the American College of Cardiology 2007;49(12):1369; author reply 1369-70.
2007: Franz H Messerli; Richard N Re
Do we need yet another blocker of the renin-angiotensin system?
Journal of the American College of Cardiology 2007;49(11):1164-5.
2007: Seth Uretsky; Sripal Bangalore; Franz H Messerli
Obesity and mortality: a poorly understood relationship.
The American journal of cardiology 2007;99(6):876-7.
2007: Hossein Eftekhari; Seth Uretsky; Franz H Messerli
Blood pressure, cognitive dysfunction, and dementia.
Journal of the American Society of Hypertension : JASH 2007;1(2):135-44.
2007: Franz H Messerli; William H Frishman; William J Elliott; Peter H Bacher; Carl J Pepine
Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
Blood pressure. Supplement 2007;1():6-9.
2007: Franz H Messerli
Amlodipine/atorvastatin for preventing heart disease.
American family physician 2007;75(3):311; author reply 311-2.
2007: Sripal Bangalore; Franz H Messerli
Effect of ramipril on the incidence of diabetes.
The New England journal of medicine 2007;356(5):522; author reply 523-4.
2007: Sripal Bangalore; Sanobar Parkar; Franz H Messerli
"One" cup of coffee and nuclear SPECT to go.
Journal of the American College of Cardiology 2007;49(4):528; author reply 528-9.
2007: John B Kostis; Philip B Gorelick; Franz H Messerli
Reduction of stroke risk factors.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(1):49-56.
2006: Sripal Bangalore; Sanobar Parkar; Franz H Messerli
How useful are beta-blockers in cardiovascular disease?
Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 2006;6(4):358-63.
2006: Franz H Messerli; Giuseppe Mancia; Charles Richard Conti; Carl J Pepine
Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European society of cardiology.
European heart journal 2006;27(23):2902-3; author reply 2903.
2006: Carl J Lavie; Richard V Milani; Hector O Ventura; Franz H Messerli
Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction.
The American journal of cardiology 2006;98(10):1396-9.
2006: Roxana Oprisiu-Fournier; Jean-Marie Serot; Jean-Michel Achard; Franz H Messerli; Sandra Black; Albert Fournier
AT1 receptor blockers for cognition decline after cardiac surgery?
Stroke; a journal of cerebral circulation 2006;37(11):2666.
2006: Franz H Messerli; Sripal Bangalore; Brent M Egan; Stevo Julius
Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension?
The American journal of cardiology 2006;98(8):1122.
2006: Sripal Bangalore; Franz H Messerli
Of statistical significance: "trends" toward significance and optimism bias.
Journal of the American College of Cardiology 2006;48(7):1471; author reply 1471.
2006: Rhonda M Cooper-DeHoff; Jerome D Cohen; George L Bakris; Franz H Messerli; Serap Erdine; Ann C Hewkin; Stuart Kupfer; Carl J Pepine
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
The American journal of cardiology 2006;98(7):890-4.
2006: Sripal Bangalore; Franz H Messerli
A review of stroke in patients with hypertension and coronary artery disease: Focus on calcium channel blockers.
International journal of clinical practice 2006;60(10):1281-6.
2006: Franz H Messerli; Gareth Beevers; Stanley S Franklin; Thomas G Pickering
Clinical trials in hypertension.
JAMA : the journal of the American Medical Association 2006;296(12):1463; author reply 1464-5.
2006: Sripal Bangalore; Franz H Messerli
Beta-blockers and exercise.
Journal of the American College of Cardiology 2006;48(6):1284-5; author reply 1285.
2006: Gurusher S Panjrath; Franz H Messerli
Beta-blockers for primary prevention in hypertension: era bygone?
Progress in cardiovascular diseases 2006;49(2):76-87.
2006: Franz H Messerli; Jan A Staessen
Amlodipine better than lisinopril? How one randomized clinical trial ended fallacies from observational studies.
Hypertension 2006;48(3):359-61.
2006: Franz H Messerli; George L Bakris; David Ferrera; Mark C Houston; Robert J Petrella; John M Flack; William Sun; EunMee Lee; Joel M Neutel
Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(8):571-81; quiz 582-3.
2006: Ehud Grossman; Franz H Messerli
Long-term safety of antihypertensive therapy.
Progress in cardiovascular diseases 2006;49(1):16-25.
2006: Ji-Guang Wang; Jan A Staessen; Yan Li; Luc M Van Bortel; Tim Nawrot; Robert Fagard; Franz H Messerli; Michel Safar
Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.
Stroke; a journal of cerebral circulation 2006;37(7):1933-40.
2006: Franz H Messerli; Giuseppe Mancia; C Richard Conti; Ann C Hewkin; Stuart Kupfer; Annette Champion; Rainer E Kolloch; ATHANASE BENETOS; Carl J Pepine
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
Annals of internal medicine 2006;144(12):884-93.
2006: Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko A Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Feasibility of treating prehypertension with an angiotensin-receptor blocker.
The New England journal of medicine 2006;354(16):1685-97.
2006: Richard V Milani; Carl J Lavie; Mandeep Mehra; Hector O Ventura; Joshua D Kurtz; Franz H Messerli
Left ventricular geometry and survival in patients with normal left ventricular ejection fraction.
The American journal of cardiology 2006;97(7):959-63.
2006: Franz H Messerli; Sripal Bangalore
Good news from Lake Wobegon.
The American journal of medicine 2006;119(1):4-5.
2005: Franz H Messerli; Jan A Staessen
Safety of calcium antagonists: more ACTION.
The American journal of medicine 2005;118(12):1418-20.
2005: George L Bakris; Vivian Fonseca; Richard E Katholi; Janet B McGill; Franz H Messerli; Robert A Phillips; Philip Raskin; Jackson T Wright; Brian Waterhouse; Mary Ann Lukas; Karen M Anderson; David S H Bell
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.
Hypertension 2005;46(6):1309-15.
2005: Franz H Messerli; Adrian W Messerli; Thomas F Lüscher
Eisenhower's billion-dollar heart attack--50 years later.
The New England journal of medicine 2005;353(12):1205-7.
2005: Franz H Messerli
Aspirin: a novel antihypertensive drug? Or two birds with one stone?
Journal of the American College of Cardiology 2005;46(6):984-5.
2005: Franz H Messerli; Tina Sichrovsky
Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease?
The American journal of cardiology 2005;96(6):872-3.
2005: Franz H Messerli; Tina Sichrovsky
When premature is not premature--the ASCOT study.
European heart journal 2005;26(18):1822-3.
2005: Franz H Messerli; Delia Cotiga
Masked hypertension and white-coat hypertension: therapeutic navigation between scylla and charybdis.
Journal of the American College of Cardiology 2005;46(3):516-7.
2005: Franz H Messerli; Ehud Grossman
Therapeutic controversies in hypertension.
Seminars in nephrology 2005;25(4):227-35.
2005: Franz H Messerli
Franz H. Messerli, MD: a conversation with the editor. Interview by William Clifford Roberts.
The American journal of cardiology 2005;96(1):154-65.
2005: Franz H Messerli
Clinical trials report. Race at ASCOT coming to a halt.
Current hypertension reports 2005;7(3):163-4.
2005: Franz H Messerli
Risk factors for renal cell carcinoma: hypertension or diuretics?
Kidney international 2005;67(2):774-5.
2005: Laurent Magy; François Vincent; Sebastien Faure; Franz H Messerli; Jiguang G Wang; Jean-Michel Achard; Albert Fournier
The renin-angiotensin systems: evolving pharmacological perspectives for cerebroprotection.
Current pharmaceutical design 2005;11(25):3275-91.
2005: Franz H Messerli; Stuart Kupfer; Carl J Pepine
J curve in hypertension and coronary artery disease.
The American journal of cardiology 2005;95(1):160.
2004: George L Bakris; Vivian Fonseca; Richard E Katholi; Janet B McGill; Franz H Messerli; Robert A Phillips; Philip Raskin; Jackson T Wright; Rosemary Oakes; Mary Ann Lukas; Karen M Anderson; David S H Bell
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;292(18):2227-36.
2004: George L Bakris; Efrain Gaxiola; Franz H Messerli; Giuseppe Mancia; Serap Erdine; Rhonda M Cooper-DeHoff; Carl J Pepine
Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.
Hypertension 2004;44(5):637-42.
2004: Rhonda M Cooper-DeHoff; Eileen Handberg; Jerome Cohen; Peter R Kowey; Franz H Messerli; Giuseppe Mancia; Jose L Cangiano; Efrain Gaxiola; David Garcia-Barreto; Ann C Hewkin; Carl J Pepine
Characteristics of contemporary patients with hypertension and coronary artery disease.
Clinical cardiology 2004;27(10):571-6.
2004: Franz H Messerli; Ehud Grossman; Gastone Leonetti
Antihypertensive therapy and new onset diabetes.
Journal of hypertension 2004;22(10):1845-7.
2004: Franz H Messerli; Albert Fournier
Re: Lawes et al: blood pressure and stroke.
Stroke; a journal of cerebral circulation 2004;35(10):2238.
2004: Franz H Messerli
TIMPs, MMPs and cardiovascular disease.
European heart journal 2004;25(17):1475-6.
2004: Ehud Grossman; Franz H Messerli
Calcium antagonists.
Progress in cardiovascular diseases 2004;47(1):34-57.
2004: Franz H Messerli; Ehud Grossman
beta-Blockers in hypertension: is carvedilol different?
The American journal of cardiology 2004;93(9A):7B-12B.
2004: Michael A Weber; Louis Michael Prisant; Henry R Black; Franz H Messerli
Treatment of elderly hypertensive patients with a delayed-release verapamil formulation in a community-based trial.
The American journal of geriatric cardiology 2004;13(3):131-6.
2004: Albert Fournier; Franz H Messerli; Jean Michel Achard; Leonardo Fernandez
Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials.
Journal of the American College of Cardiology 2004;43(8):1343-7.
2004: Franz H Messerli
Effects of losartan in hypertension without vascular disease.
Annals of internal medicine 2004;140(7):W29.
2004: Franz H Messerli
Calcium antagonists and beta-blockers: impact on cardiovascular and cerebrovascular events.
Clinical cornerstone 2004;6(4):18-27.
2004: Ehud Grossman; Franz H Messerli
Are calcium antagonists beneficial in diabetic patients with hypertension?
The American journal of medicine 2004;116(1):44-9.
2003: Franz H Messerli
Vascular protection of ACE inhibitors.
Archives of internal medicine 2003;163(22):2791-2; author reply 2792-3.
2003: Carl J Pepine; Eileen Handberg; Rhonda M Cooper-DeHoff; Ronald G Marks; Peter R Kowey; Franz H Messerli; Giuseppe Mancia; Jose L Cangiano; David Garcia-Barreto; Mátyás Keltai; Serap Erdine; Heather A Bristol; H Robert Kolb; George L Bakris; Jerome D Cohen; William W Parmley
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
JAMA : the journal of the American Medical Association 2003;290(21):2805-16.
2003: Franz H Messerli; Ehud Grossman; Anthony F Lever
Do thiazide diuretics confer specific protection against strokes?
Archives of internal medicine 2003;163(21):2557-60.
2003: Franz H Messerli
ALLHAT, or the soft science of the secondary end point.
Annals of internal medicine 2003;139(9):777-80.
2003: Franz H Messerli
Of millimeterology and cannibalism: comparative antihypertensive efficacy of angiotensin receptor blockers.
American heart journal 2003;146(4):568-9.
2003: Franz H Messerli; D Gareth Beevers; Stanley S Franklin; Thomas G Pickering
beta-Blockers in hypertension-the emperor has no clothes: an open letter to present and prospective drafters of new guidelines for the treatment of hypertension.
American journal of hypertension 2003;16(10):870-3.
2003: Franz H Messerli; Michael A Weber
ALLHAT--all hit or all miss? Key questions still remain.
The American journal of cardiology 2003;92(3):280-1.
2003: Arnfried U Klingbeil; Markus Schneider; Peter Martus; Franz H Messerli; Roland E Schmieder
A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.
The American journal of medicine 2003;115(1):41-6.
2003: Carl J Lavie; Richard V Milani; Franz H Messerli
Obesity and the heart: an ever-growing problem.
Southern medical journal 2003;96(6):535-6.
2003: Franz H Messerli; Michael A Weber
Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
JAMA : the journal of the American Medical Association 2003;289(16):2067-8; author reply 2069-70.
2003: Franz H Messerli
The LIFE study: the straw that should break the camel's back.
European heart journal 2003;24(6):487-9.
2003: Franz H Messerli; Ehud Grossman; Albert Fournier
Losartan vs atenolol in prevention of stroke and cardiovascular disease.
JAMA : the journal of the American Medical Association 2003;289(6):700-1; author reply 701.
2003: Franz H Messerli
Evolution of calcium antagonists: past, present, and future.
Clinical cardiology 2003;26(2 Suppl 2):II12-6.
2002: Franz H Messerli; William B White; Jan A Staessen
If only cardiologists did properly measure blood pressure. Blood pressure recordings in daily practice and clinical trials.
Journal of the American College of Cardiology 2002;40(12):2201-3.
2002: Franz H Messerli; Mandeep Mehra
Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [LIFE] Study).
The American journal of cardiology 2002;90(10):1133-4.
2002: Franz H Messerli; Ehud Grossman
Pedal edema--not all dihydropyridine calcium antagonists are created equal.
American journal of hypertension 2002;15(11):1019-20.
2002: Franz H Messerli
Vasodilatory edema: a common side effect of antihypertensive therapy.
Current cardiology reports 2002;4(6):479-82.
2002: Ehud Grossman; Franz H Messerli
Why beta-blockers are not cardioprotective in elderly patients with hypertension.
Current cardiology reports 2002;4(6):468-73.
2002: Franz H Messerli; Ehud Grossman
Beta-blocker therapy and depression.
JAMA : the journal of the American Medical Association 2002;288(15):1845-6; author reply 1846.
2002: Yehonatan Sharabi; R Illan; Yehuda Kamari; H Cohen; Moshe Nadler; Franz H Messerli; Ehud Grossman
Diuretic induced hyponatraemia in elderly hypertensive women.
Journal of human hypertension 2002;16(9):631-5.
2002: Franz H Messerli; Daniel F Hanley; Philip B Gorelick
Blood pressure control in stroke patients: what should the consulting neurologist advise?
Neurology 2002;59(1):23-5.
2002: Franz H Messerli
Calcium antagonists in hypertension: from hemodynamics to outcomes.
American journal of hypertension 2002;15(7 Pt 2):94S-97S.
2002: Franz H Messerli; Matthew R Weir; Joel M Neutel
Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting.
American journal of hypertension 2002;15(6):550-6.
2002: Ehud Grossman; Franz H Messerli; Uri Goldbourt
Carcinogenicity of antihypertensive therapy.
Current hypertension reports 2002;4(3):195-201.
2002: Carl J Lavie; Richard Milani; Mandeep Mehra; Hector O Ventura; Franz H Messerli
Obesity, weight reduction and survival in heart failure.
Journal of the American College of Cardiology 2002;39(9):1563; author reply 1563-4.
2002: Ehud Grossman; Franz H Messerli; Valentina Boyko; Uri Goldbourt
Is there an association between hypertension and cancer mortality?
The American journal of medicine 2002;112(6):479-86.
2001: Franz H Messerli
Doxazosin and congestive heart failure.
Journal of the American College of Cardiology 2001;38(5):1295-6.
2001: E Grossman; Franz H Messerli; U Goldbourt
Antihypertensive therapy and the risk of malignancies.
European heart journal 2001;22(15):1343-52.
2001: Franz H Messerli; J F Hansen; R S Gibson; K B Schechtman; W E Boden
Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients.
Journal of hypertension 2001;19(5):977-82.
2001: C E Okereke; Franz H Messerli
Efficacy and safety of angiotensin II receptor blockers in elderly patients with mild to moderate hypertension.
The American journal of geriatric cardiology 2001;10(1):42-9.
2000: Franz H Messerli; S Oparil; Z Feng
Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
The American journal of cardiology 2000;86(11):1182-7.
2000: Roland E Schmieder; Franz H Messerli
Hypertension and the heart.
Journal of human hypertension 2000;14(10-11):597-604.
2000: Ehud Grossman; Franz H Messerli; J M Neutel
Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?
Archives of internal medicine 2000;160(13):1905-11.
2000: Franz H Messerli; Ehud Grossman
Doxazosin arm of the ALLHAT study discontinued: how equal are antihypertensive drugs? Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial.
Current hypertension reports 2000;2(3):241-2.
1999: Franz H Messerli; E Grossman
Beta-blockers and diuretics: to use or not to use.
American journal of hypertension 1999;12(12 Pt 1-2):157S-163S.
1999: Franz H Messerli
Hypertension and sudden cardiac death.
American journal of hypertension 1999;12(12 Pt 3):181S-188S.
1999: Franz H Messerli
Outcome studies--are all antihypertensive drugs created equal?
Journal of the American College of Cardiology 1999;34(5):1652-3.
1999: Franz H Messerli; E Grossman
The use of sublingual nifedipine: a continuing concern.
Archives of internal medicine 1999;159(19):2259-60.
1999: Franz H Messerli
Combinations in the treatment of hypertension: ACE inhibitors and calcium antagonists.
American journal of hypertension 1999;12(8 Pt 2):86S-90S.
1999: Franz H Messerli
New directions in the management of hypertension and the cardiovascular risk. Introduction.
American journal of hypertension 1999;12(8 Pt 2):63S-64S.
1999: E Grossman; Franz H Messerli; U Goldbourt
Carcinogenicity of cardiovascular drugs.
Current hypertension reports 1999;1(3):212-8.
1999: Franz H Messerli; E Grossman
Diuretics, beta-blockers, and gin and tonic.
European heart journal 1999;20(1):25-30.
1998: Franz H Messerli; E Grossman
The calcium antagonist controversy: a posthumous commentary.
The American journal of cardiology 1998;82(9B):35R-39R.
1998: Franz H Messerli; B S Mittler
Framingham at 50.
Lancet 1998;352(9133):1006.
1998: Franz H Messerli; E Grossman; U Goldbourt
Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.
JAMA : the journal of the American Medical Association 1998;279(23):1903-7.
1998: Franz H Messerli; L Michalewicz
Fixed drug combinations in the treatment of hypertension: how to identify the optimal dose.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1998;16(1):S81-4.
1997: Franz H Messerli; R E Schmieder; Matthew R Weir
Salt. A perpetrator of hypertensive target organ disease?
Archives of internal medicine 1997;157(21):2449-52.
1997: Franz H Messerli; E Grossman; L Michalewicz
Combination therapy and target organ protection in hypertension and diabetes mellitus.
American journal of hypertension 1997;10(9 Pt 2):198S-201S.
1997: J K Rockstroh; Roland E Schmieder; Markus P Schlaich; Franz H Messerli
Renal and systemic hemodynamics in black and white hypertensive patients.
American journal of hypertension 1997;10(9 Pt 1):971-8.
1997: Franz H Messerli; L Michalewicz
Safety of heart rate-lowering calcium antagonists: lessons from controlled trials.
American heart journal 1997;134(2 Pt 2):S21-4.
1997: Franz H Messerli; L Michalewicz
Cardiac effects of combination therapy.
American journal of hypertension 1997;10(7 Pt 2):146S-152S.
1997: Roland E Schmieder; J K Rockstroh; G Lüchters; U Hammerstein; Franz H Messerli
Comparison of early target organ damage between blacks and whites with mild systemic arterial hypertension.
The American journal of cardiology 1997;79(12):1695-8.
1997: L Michalewicz; Franz H Messerli
Cardiac effects of calcium antagonists in systemic hypertension.
The American journal of cardiology 1997;79(10A):39-46; discussion 47-8.
1997: F C Aepfelbacher; Franz H Messerli; E Nunez; E D Frohlich
Disparate effects of ACE-inhibitors and calcium antagonists on left ventricular structure and function in essential hypertension.
Journal of human hypertension 1997;11(5):321-5.
1997: F C Aepfelbacher; Franz H Messerli; E Nunez; L Michalewicz
Cardiovascular effects of a trandolapril/verapamil combination in patients with mild to moderate essential hypertension.
The American journal of cardiology 1997;79(6):826-8.
1997: Franz H Messerli; L Michalewicz
Hypertensive heart disease, ventricular dysrhythmias, and sudden death.
Advances in experimental medicine and biology 1997;432():263-72.
1997: Franz H Messerli; L Michalewicz
Effects of combination therapy on the heart.
Journal of human hypertension 1997;11(1):29-33.
1997: George L Bakris; Franz H Messerli
The Lanai Symposium: hypertensive patient profiles: approaches to management and disease prevention.
Journal of human hypertension 1997;11(1):7-8.
1996: Franz H Messerli
What, if anything, is controversial about calcium antagonists?
American journal of hypertension 1996;9(12 Pt 2):177S-181S.
1996: Franz H Messerli
Safety of calcium antagonists: dissecting the evidence.
The American journal of cardiology 1996;78(9A):19-23.
1996: Franz H Messerli; T Grodzicki
Hypertension and coronary artery disease in the elderly.
Clinics in geriatric medicine 1996;12(1):41-56.
1995: Franz H Messerli; F C Aepfelbacher
Hypertension and left-ventricular hypertrophy.
Cardiology clinics 1995;13(4):549-57.
1995: J Jordan; Franz H Messerli; Carl J Lavie; F C Aepfelbacher; F Soria
Reduction of weight and left ventricular mass with serotonin uptake inhibition in obese patients with systemic hypertension.
The American journal of cardiology 1995;75(10):743-4.
1995: E Grossman; Franz H Messerli
High blood pressure. A side effect of drugs, poisons, and food.
Archives of internal medicine 1995;155(5):450-60.
1994: B D Nunez; Carl J Lavie; Franz H Messerli; Roland E Schmieder; G E Garavaglia; M Nunez
Comparison of diastolic left ventricular filling and cardiac dysrhythmias in hypertensive patients with and without isolated septal hypertrophy.
The American journal of cardiology 1994;74(6):585-9.
1994: Franz H Messerli; F Soria
Ventricular dysrhythmias, left ventricular hypertrophy, and sudden death.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1994;8 Suppl 3():557-63.
1994: D Aristizabal; Franz H Messerli; ED Frohlich
Disparate structural effects on left and right ventricles by angiotensin-converting enzyme inhibitors and calcium antagonists in essential hypertension.
The American journal of cardiology 1994;73(7):483-7.
1994: R Ketelhut; C J Losem; Franz H Messerli
Is a decrease in arterial pressure during long-term aerobic exercise caused by a fall in cardiac pump function?
American heart journal 1994;127(3):567-71.
1994: Franz H Messerli
Introduction: antihypertensive therapy: past, present, and future.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1994;8 Suppl 1():7-9.
1993: T Grodzicki; Franz H Messerli; F Soria; D Aristizabal; ED Frohlich
Determinants of left ventricular mass reduction in essential hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S364-5.
1993: E Grossman; Franz H Messerli; S Oren; F Soria; Roland E Schmieder
Disparate cardiovascular response to stress tests during isradipine and fosinopril therapy.
The American journal of cardiology 1993;72(7):574-9.
1993: Franz H Messerli; F Soria; D Aristizabal
Left ventricular hypertrophy: should it be reduced?
Clinical cardiology 1993;16(5 Suppl 2):II15-20.
1993: Franz H Messerli; D Aristizabal; F Soria
Reduction of left ventricular hypertrophy: how beneficial?
American heart journal 1993;125(5 Pt 2):1520-4.
1993: Franz H Messerli; F Soria
[Hypertension, left ventricular hypertrophy and cardiovascular morbidity and mortality].
Cardiology 1993;82 Suppl 1():30-6.
1993: Franz H Messerli; R Ketelhut
Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor.
Journal of cardiovascular pharmacology 1993;22 Suppl 1():S7-13.
1992: Franz H Messerli
Combination therapy in hypertension.
Journal of human hypertension 1992;6 Suppl 2():S19-21.
1992: Franz H Messerli; T Grodzicki
Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death.
European heart journal 1992;13 Suppl D():66-9.
1992: Franz H Messerli; F Soria
Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden death.
The American journal of medicine 1992;93(2A):21S-26S.
1992: R Ketelhut; C J Losem; Franz H Messerli
Depressed systolic and diastolic cardiac function after prolonged aerobic exercise in healthy subjects.
International journal of sports medicine 1992;13(4):293-7.
1992: Franz H Messerli; T Grodzicki
Hypertensive heart disease: to use or not to use diuretics?
Clinical and experimental hypertension. Part A, Theory and practice 1992;14(3):343-6.
1992: Roland E Schmieder; Franz H Messerli
Determinants of ventricular ectopy in hypertensive cardiac hypertrophy.
American heart journal 1992;123(1):89-95.
1992: Franz H Messerli; F Soria
Selection of antihypertensive therapy: cardiac and extracardiac considerations.
Cardiology 1992;81(4-5):316-24.
1992: Franz H Messerli; F Soria
Does a reduction in left ventricular hypertrophy reduce cardiovascular morbidity and mortality?
Drugs 1992;44 Suppl 1():141-6.
1991: ED Frohlich; M J McLoughlin; C J Losem; R Ketelhut; Franz H Messerli
Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension.
The American journal of cardiology 1991;68(13):1346-50.
1991: R Ketelhut; Franz H Messerli
Hypertension: left ventricular hypertrophy, ventricular ectopy, and sudden death.
Primary care 1991;18(3):577-92.
1991: ED Frohlich; R Ketelhut; U R Kaesser; C J Losem; Franz H Messerli
Hemodynamic effects of celiprolol in essential hypertension.
The American journal of cardiology 1991;68(5):509-14.
1991: E Grossman; S Oren; Franz H Messerli
Left ventricular filling in the systemic hypertension of obesity.
The American journal of cardiology 1991;68(1):57-60.
1991: E Grossman; Franz H Messerli; S Oren; B Nunez; G E Garavaglia
Cardiovascular effects of isradipine in essential hypertension.
The American journal of cardiology 1991;68(1):65-70.
1991: S Oren; Franz H Messerli; E Grossman; G E Garavaglia; ED Frohlich
Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.
Journal of the American College of Cardiology 1991;17(5):1183-7.
1991: Franz H Messerli; R Ketelhut
Left ventricular hypertrophy: an independent risk factor.
Journal of cardiovascular pharmacology 1991;17 Suppl 4():S59-66; discussion S66-7.
1990: Franz H Messerli
Left ventricular hypertrophy, arterial hypertension and sudden death.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1990;8(7):S181-6.
1990: Franz H Messerli
Considerations in treating hypertension: focus on risk factors.
Journal of human hypertension 1990;4 Suppl 5():3-6.
1990: Franz H Messerli; C J Losem
Antihypertensive therapy in the elderly.
Clinics in geriatric medicine 1990;6(2):335-44.
1990: Franz H Messerli
Antihypertensive therapy--going to the heart of the matter.
Circulation 1990;81(3):1128-35.
1990: Franz H Messerli
Antihypertensive therapy. Is it different in the elderly?
Drugs 1990;39 Suppl 2():49-54.
1989: G E Garavaglia; Franz H Messerli; Roland E Schmieder; B D Nunez; S Oren
Sex differences in cardiac adaptation to essential hypertension.
European heart journal 1989;10(12):1110-4.
1989: Franz H Messerli; U R Kaesser; C J Losem
Effects of antihypertensive therapy on hypertensive heart disease.
Circulation 1989;80(6 Suppl):IV145-50.
1989: E Grossman; S Oren; G E Garavaglia; Roland E Schmieder; Franz H Messerli
Disparate hemodynamic and sympathoadrenergic responses to isometric and mental stress in essential hypertension.
The American journal of cardiology 1989;64(1):42-4.
1989: Roland E Schmieder; Franz H Messerli; D Sturgill; G E Garavaglia; B D Nunez
Cardiac performance after reduction of myocardial hypertrophy.
The American journal of medicine 1989;87(1):22-7.
1989: E Grossman; Franz H Messerli; S Oren; A A MacPhee
Hemodynamic and humoral effects of intravenous dilevalol in patients with moderate hypertension.
The American journal of cardiology 1989;63(19):34I-37I.
1989: Franz H Messerli; U R Kaesser
Lisinopril in the treatment of hypertension.
Journal of human hypertension 1989;3 Suppl 1():17-21.
1989: Franz H Messerli; B D Nunez; M M Nunez; G E Garavaglia; Roland E Schmieder; Hector O Ventura
Hypertension and sudden death. Disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmias.
Archives of internal medicine 1989;149(6):1263-7.
1988: G E Garavaglia; Franz H Messerli; Roland E Schmieder; B D Nunez
Antihypertensive therapy and cardiovascular reactivity during isometric stress.
Journal of human hypertension 1988;2(4):247-51.
1988: E Grossman; S Oren; G E Garavaglia; Franz H Messerli; ED Frohlich
Systemic and regional hemodynamic and humoral effects of nitrendipine in essential hypertension.
Circulation 1988;78(6):1394-400.
1988: Roland E Schmieder; Franz H Messerli; B D Nunez; G E Garavaglia; ED Frohlich
Hemodynamic, humoral and volume findings in systemic hypertension with isolated ventricular septal hypertrophy.
The American journal of cardiology 1988;62(16):1053-7.
1988: S Oren; E Grossman; Franz H Messerli; ED Frohlich
High blood pressure: side effects of drugs, poisons, and food.
Cardiology clinics 1988;6(4):467-74.
1988: G E Garavaglia; Franz H Messerli; B D Nunez; Roland E Schmieder; ED Frohlich
Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension.
The American journal of cardiology 1988;62(13):912-6.
1988: Roland E Schmieder; Franz H Messerli; G E Garavaglia; B D Nunez
Dietary salt intake. A determinant of cardiac involvement in essential hypertension.
Circulation 1988;78(4):951-6.
1988: G E Garavaglia; Franz H Messerli; B D Nunez; Roland E Schmieder; E Grossman
Myocardial contractility and left ventricular function in obese patients with essential hypertension.
The American journal of cardiology 1988;62(9):594-7.
1988: Franz H Messerli
The heterogeneity of essential hypertension: hemodynamic aspects.
American heart journal 1988;116(2 Pt 2):590-3.
1988: G E Garavaglia; Franz H Messerli; B D Nunez; Roland E Schmieder; ED Frohlich
Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
American journal of hypertension 1988;1(3 Pt 3):214S-216S.
1988: Franz H Messerli
Haemodynamic effects of urapidil in arterial hypertension and congestive heart failure.
Drugs 1988;35 Suppl 6():70-3.
1988: Franz H Messerli; S Oren; E Grossman
Left ventricular hypertrophy and antihypertensive therapy.
Drugs 1988;35 Suppl 5():27-33.
1988: Franz H Messerli
Effects of calcium channel blockade on cardiac repercussions of long-standing hypertension.
Journal of cardiovascular pharmacology 1988;12 Suppl 6():S44-7.
1987: Carl J Lavie; C Amodeo; Hector O Ventura; Franz H Messerli
Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiopathy of obesity.
Chest 1987;92(6):1042-6.
1987: B D Nunez; Franz H Messerli; C Amodeo; G E Garavaglia; Roland E Schmieder; ED Frohlich
Biventricular cardiac hypertrophy in essential hypertension.
American heart journal 1987;114(4 Pt 1):813-8.
1987: Franz H Messerli; B D Nunez; Hector O Ventura; D W Snyder
Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity.
Archives of internal medicine 1987;147(10):1725-8.
1986: C Amodeo; I Kobrin; Hector O Ventura; Franz H Messerli; ED Frohlich
Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension.
Circulation 1986;73(1):108-13.
1985: C Amodeo; Franz H Messerli; Hector O Ventura; I Kobrin; G Garavaglia; B Nuñez; ED Frohlich
Disparate cardiac effects of afterload reduction in hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1985;3(3):S371-3.
1985: I Kobrin; C Amodeo; Hector O Ventura; Franz H Messerli; ED Frohlich
Immediate hemodynamic effects of urapidil in patients with essential hypertension.
The American journal of cardiology 1985;55(6):722-5.